GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

fontolizumab   Click here for help

GtoPdb Ligand ID: 9847

Synonyms: HuZAF
Immunopharmacology Ligand
Compound class: Antibody
Comment: Fontolizumab (HuZAF) is a humanized anti-IFNγ mAb designed for the treatment of auto-immune diseases like Crohn's disease. This antibody is claimed in patent US6329511 [4]. It is one of the novel agents for immune-mediated inflammatory diseases discussed in Baker et al. (2018) [1].
Bioactivity Comments
Fontolizumab neutralises the proinflammatory activity of IFNγ, as measured by antibody-mediated reduction in IFNγ-induced upregulation of MHC II expression by Hs294T melanoma cells [4].
Selectivity at ligand targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
IFN-γ Primary target of this compound Hs Antibody Binding - - - 4
⤷ [4]